Leslie Meltzer
Chief Tech/Sci/R&D Officer presso ORCHARD THERAPEUTICS PLC
Profilo
Leslie Meltzer is currently the Chief Medical Officer at Orchard Therapeutics Plc.
Prior to this role, Dr. Meltzer served as the Vice President-Medical Affairs at Keryx Biopharmaceuticals, Inc. from 2016 to 2018.
Dr. Meltzer holds a doctorate degree from Stanford University School of Medicine.
Posizioni attive di Leslie Meltzer
Società | Posizione | Inizio |
---|---|---|
ORCHARD THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Precedenti posizioni note di Leslie Meltzer
Società | Posizione | Fine |
---|---|---|
KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Formazione di Leslie Meltzer
Stanford University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Leslie Meltzer